Poly Medicure Limited has announced that a meeting of its Board of Directors is scheduled for May 25, 2026. The primary agenda involves the approval of the company’s audited financial results for the financial year ending March 31, 2026. Furthermore, the board will evaluate a recommendation for a final dividend on equity shares for the same period. The company also confirmed that its trading window will remain closed until May 27, 2026.
Upcoming Board Meeting Details
Poly Medicure Limited is set to hold a crucial Board of Directors meeting on Monday, May 25, 2026. The session will focus on the review and approval of the audited consolidated and standalone financial results for the fiscal year that concluded on March 31, 2026. This disclosure serves as a key update for stakeholders as the company prepares to announce its annual performance.
Dividend Consideration
In addition to the financial reporting, the board is scheduled to discuss the potential declaration of a final dividend on the company’s equity shares for the financial year ended March 31, 2026. Any final decision regarding the dividend payout will be announced following the conclusion of the board proceedings.
Trading Window Closure
In adherence to corporate governance practices, Poly Medicure Limited has maintained a closed trading window for its securities. This restriction, which began on March 27, 2026, will continue to remain in effect until May 27, 2026, ensuring that trading activities remain restricted until the financial results are made public.
Source: BSE
